Amanote Research
Register
Sign In
Oncogenic Mutations and Dysregulated Pathways in Obesity-Associated Hepatocellular Carcinoma
Oncogene
- United Kingdom
doi 10.1038/onc.2016.162
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Genetics
Molecular Biology
Date
May 2, 2016
Authors
J Shen
H Tsoi
Q Liang
E S H Chu
D Liu
A C-S Yu
T F Chan
X Li
J J Y Sung
V W S Wong
J Yu
Publisher
Springer Science and Business Media LLC
Related search
K-Ras Mutation Subtypes in NSCLC and Associated Co-Occuring Mutations in Other Oncogenic Pathways
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Oncogenic Wnt3a: A Promising Specific Biomarker in Hepatocellular Carcinoma
Hepatoma Research
A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells
PLoS ONE
Multidisciplinary
Obesity Independently Drives NASH and Hepatocellular Carcinoma
Cancer Discovery
Oncology
Oncogenic Function and Prognostic Significance of Abelson Interactor 1 in Hepatocellular Carcinoma
International Journal of Oncology
Cancer Research
Oncology
WNT Status-Dependent Oncogenic Role of BCL9 and BCL9L in Hepatocellular Carcinoma
Hepatology International
Hepatology
CDK8 and CDK19 Kinases Have Non-Redundant Oncogenic Functions in Hepatocellular Carcinoma
GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma
Journal of the American College of Surgeons
Surgery
Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma
Frontiers in Genetics
Genetics
Molecular Medicine
